Deal Won — €7,800 saved
DocuSign · Closed Apr 5
DocuSign
Deal closed — €7,800 saved
2 issues identified. Key concerns: 15 of 40 seats unused, no loyalty discount after 2 years. Estimated savings potential: 33% of total.
€24,000
12 months
€16,200
€7,800
achieved
Apr 5, 2026
Deal snapshot
Score breakdown
2 red flags found
Each issue includes what to ask for and a fallback position
15 unused seats x €50/month = €750/month = €9,000/year going to waste. Right-sizing to 30 seats (25 active + 5 buffer) costs €1,500/month instead of €2,000/month. That's €500/month saved = €6,000/year.
What to ask for
Reduce from 40 to 30 seats — €1,500/month instead of €2,000 (saves €6,000/year)
Fallback position
Reduce to 35 seats — saves €3,000/year
DocuSign account managers have authority to apply 10-15% renewal discounts for customers over 12 months — especially when a competitor quote is in play. On a right-sized €18,000/year contract, a 10% discount saves €1,800/year. You're not getting it because you haven't asked.
What to ask for
10% loyalty discount on renewal — saves €1,800/year on adjusted contract
Fallback position
5% discount — saves €900/year
- •At €50/user/month, pricing sits at the high end of the e-signature market.
- •Auto-renewal with 30-day notice is standard for this category, but worth a calendar reminder.
- •No SSO/usage report was included to confirm the active-seat count independently.
Your negotiation playbook
What to push for, your leverage, and what to offer in return
Push For
Your Leverage
Can Offer
Savings Impact
Original quote
€24,000
After savings
€16,200
33% potential reduction
Must-have savings
Ready-to-send negotiation email
Pick a tone, customize if needed, and send it
Click to edit subject and body
Negotiation rounds
Round 1 — Initial analysis
Mar 28
Deal closed — Won
Apr 5 · €7,800 saved
See the full breakdown
Wins secured, timeline, shareable card
Assumptions
•25 of 40 licensed seats are actively used based on last-login data
•PandaDoc Business at ~€35/user/month used as competitive benchmark
This analysis is for informational purposes only and does not constitute legal, financial, or professional advice.